Compile Data Set for Download or QSAR

Found 2 hits Enz. Inhib. hit(s) with Target = 'Melanocyte-stimulating hormone receptor' and Ligand = 'BDBM250690'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Melanocyte-stimulating hormone receptor (Homo sapiens (Human))	BDBM250690 (US9447148, 9.59) Show SMILES CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CCC(=O)NCC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](CCCN)NC1=O)C(N)=O |r| Show InChI InChI=1S/C37H59ClN12O8/c1-3-4-7-25(45-21(2)51)32(54)49-28-14-15-30(52)43-19-16-24(31(40)53)46-33(55)27(9-6-18-44-37(41)42)48-36(58)29(20-22-10-12-23(38)13-11-22)50-34(56)26(8-5-17-39)47-35(28)57/h10-13,24-29H,3-9,14-20,39H2,1-2H3,(H2,40,53)(H,43,52)(H,45,51)(H,46,55)(H,47,57)(H,48,58)(H,49,54)(H,50,56)(H4,41,42,44)/t24-,25-,26-,27-,28-,29+/m0/s1	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	2	-51.6	n/a	n/a	n/a	n/a	n/a	7.5	37
Palatin Technologies, Inc. US Patent					Assay Description A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...				US Patent US9447148 (2016) BindingDB Entry DOI: 10.7270/Q2RJ4HD2
					More data for this Ligand-Target Pair
Melanocyte-stimulating hormone receptor (Homo sapiens (Human))	BDBM250690 (US9447148, 9.59) Show SMILES CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CCC(=O)NCC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](CCCN)NC1=O)C(N)=O |r| Show InChI InChI=1S/C37H59ClN12O8/c1-3-4-7-25(45-21(2)51)32(54)49-28-14-15-30(52)43-19-16-24(31(40)53)46-33(55)27(9-6-18-44-37(41)42)48-36(58)29(20-22-10-12-23(38)13-11-22)50-34(56)26(8-5-17-39)47-35(28)57/h10-13,24-29H,3-9,14-20,39H2,1-2H3,(H2,40,53)(H,43,52)(H,45,51)(H,46,55)(H,47,57)(H,48,58)(H,49,54)(H,50,56)(H4,41,42,44)/t24-,25-,26-,27-,28-,29+/m0/s1	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.100	n/a	n/a	7.5	37
Palatin Technologies, Inc. US Patent					Assay Description Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...				US Patent US9447148 (2016) BindingDB Entry DOI: 10.7270/Q2RJ4HD2
					More data for this Ligand-Target Pair